Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accounts Payables: 2023-2025

Historic Accounts Payables for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $4.0 million.

  • Upstream Bio's Accounts Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 19.33%. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Accounts Payables is $4.0 million, which was up 54.92% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Accounts Payables peaked at $4.9 million during Q3 2024, and registered a low of $2.0 million during Q4 2023.
  • Over the past 3 years, Upstream Bio's median Accounts Payables value was $4.0 million (recorded in 2024), while the average stood at $3.7 million.
  • In the last 5 years, Upstream Bio's Accounts Payables surged by 103.07% in 2024 and then dropped by 19.33% in 2025.
  • Over the past 3 years, Upstream Bio's Accounts Payables (Quarterly) stood at $2.0 million in 2023, then soared by 103.07% to $4.0 million in 2024, then decreased by 19.33% to $4.0 million in 2025.
  • Its Accounts Payables stands at $4.0 million for Q3 2025, versus $2.6 million for Q2 2025 and $4.7 million for Q1 2025.